M. Martínez-Montiel

Pharmacologic therapy for inflammatory bowel disease refractory to steroids

G. Castellano-Tortajada, MP Martínez-Montiel, B Casis-Herce, 2015, Clinical and experimental gastroenterology.

Biologic therapies for chronic inflammatory bowel disease.

M. Martínez-Montiel, M. T. Muñoz-Yagüe, 2006, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.

Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient.

M. Martínez-Montiel, J. Gonzalo, Pilar Piedracoba-Cadahia, 2015, Journal of Crohn's & colitis.

Prevalence and Factors Associated with Fatigue in Patients with Inflammatory Bowel Disease: A Multicenter Study.

F. Casellas, J. Gisbert, J. Banales, 2019, Journal of Crohn's & colitis.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.